| scholarly article | Q13442814 |
| P2093 | author name string | H. Yamamoto | |
| M. Iida | |||
| T. Takayanagi | |||
| M. Konagaya | |||
| I. Sobue | |||
| P433 | issue | 8165 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 418-419 | |
| P577 | publication date | 1980-02-01 | |
| 1980-02-23 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration | |
| P478 | volume | 1 |
| Q44473638 | Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species |
| Q70178679 | Biochemical and autoradiographic studies of TRH receptors in sections of rabbit spinal cord |
| Q28360952 | Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease |
| Q48189671 | Effects of a new TRH analogue, YM-14673 on the central nervous system |
| Q72537472 | Immune complex and mite antigen in Kawasaki disease |
| Q48794628 | Influence of the route of administration on thyrotropin-releasing hormone concentration in the mouse brain |
| Q42241108 | Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain? |
| Q67992841 | Low doses of TRH in amyotrophic lateral sclerosis and in other neurological diseases |
| Q34330977 | Pharmacological treatments of cerebellar ataxia |
| Q71614057 | Pituitary responses to a neuroactive tripeptide (TRH) in Friedreich's ataxia families |
| Q72591275 | Protirelin tartrate (TRH-T) in upper motoneuron syndrome: a controlled neurophysiological and clinical study |
| Q47895386 | Successful treatment of progressive myoclonus epilepsy with TRH. |
| Q42990013 | Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats |
| Q72537477 | TRH and spinocerebellar degeneration |
| Q44004378 | TRH treatment in cerebellar ataxia following a lightning stroke |
| Q42208959 | The effects of TRH analogues on cerebral ischaemia produced by middle cerebral artery occlusion in the rat. |
| Q34601489 | The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems |
| Q34770654 | Thyrotropin-releasing hormone (TRH) in the cerebellum |
| Q34432815 | Thyrotropin-releasing hormone: role in the treatment of West syndrome and related epileptic encephalopathies |
| Q24193064 | Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes |
| Q52100580 | What Does Brain Thyrotropin-Releasing Hormone Do? |
Search more.